Search results

Please enter search term
Slaughter and May is advising Telecom Plus PLC on its proposed return of capital of up to £25 million to shareholders Slaughter and May is advising Telecom Plus PLC on its proposed return of capital of up to £25 million to shareholders through a tender offer and subsequent repurchase of ordinary shares. The tender offer is expected to complete on 3 July 2017. Telecom Pl... Slaughter and May has advised Credit Suisse on the HK$561 million secondary placing and sale of shares in Meitu, Inc. Slaughter and May has advised Credit Suisse (Hong Kong) Limited, as the manager, in relation to the HK$561 million secondary placing and sale of shares in Meitu, Inc. The placing and sale of shares represents approximately 1.6% of the issued share capital... Slaughter and May advised DBS, Citi and BOC on the initial public offering of Sasseur REIT Slaughter and May advised DBS, Citi and BOC on the initial public offering of Sasseur REIT Slaughter and May is advising Aviva Ventures – Series A investment in Neos Slaughter and May advised Aviva Ventures on its Series A equity investment in Neos, a company which combines smart home technology with home insurance in the UK. Aviva Ventures led the £5m investment together with Munich Re Slaughter and May, Hong Kong advised Shanghai Zendai Property Limited – RMB632 million loan facility funded by loan participation notes Slaughter and May, Hong Kong, advised Shanghai Zendai Property Limited (Zendai) on a RMB632 million loan facility of its subsidiary Richtex Holdings Limited which is guaranteed by China Orient Asset Management (International) Holding Limited (COAMI). The ... Slaughter and May advised Pacific Equity Partners and The Carlyle Group on the joint acquisition of the iNova Pharmaceuticals business from Valeant Pharmaceuticals International, Inc. for US$930 million Slaughter and May advised on the on the Hong Kong aspects of the joint acquisition of the iNova Pharmaceuticals business by Pacific Equity Partners and The Carlyle Group from Valeant Pharmaceuticals International, Inc. for US$930 million. Slaughter and May is advising CIMB Group Holdings Berhad, one of ASEAN’s leading universal banking groups, on a stockbroking joint venture with China Galaxy Securities Co.Ltd., one of the PRC’s leading integrated service providers in the securities industry. Slaughter and May, Hong Kong, as Hong Kong counsel, advised TOKIN Corporation (with Mori Hamada & Matsumoto, as transaction counsel) on the sale of its electro-mechanical devices business to NTJ Holdings 1 Ltd. Slaughter and May advised Wood Group in relation to its US$2.75bn pre-bid refinancing Slaughter and May advised Wood Group in relation to the US$ 2.75 billion of committed syndicated term and revolving credit facilities (comprising a US$ 1 billion three year term loan facility and a US$ 1.75 billion five year revolving credit facility), pu... Slaughter and May advised FirstGroup plc on the amendment and extension of its existing multi-currency revolving credit and guarantee facility totalling £800 million The facility was extended by two years, to 10 July 2021. The amendments also included improved pricing. Slaughter and May advised Linde AG on the UK tax law aspects and certain UK corporate law aspects of its combination with Praxair, Inc. Slaughter and May advised Linde AG on the UK tax law aspects and certain UK corporate law aspects of its combination with Praxair, Inc.